ANNE HUY: Open Payments
NPI 1194772137 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 19 payments from 10 companies in 2025. Trend: 2023 $140 · 2024 $87 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $117 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Rybelsus, SHINGRIX, XIFAXAN, LEQVIO, INSPIRE, PAXLOVID, JARDIANCE, QULIPTA.
Industry payments across PA — which companies pay providers there.
